Wigati, Dyan and Setyowati, Erna Prawita and Pratiwi, Sylvia Utami Tunjung and Nugraha, Ari Satia (2024) Promising sponge derived marine fungi as antibacterial and biofilm inhibitors. Journal of Applied Pharmaceutical Science, 14 (4). 14 – 34. ISSN 22313354
Full text not available from this repository. (Request a copy)Abstract
Marine organisms, especially sponges, provide many sources of metabolites with various biological activities. Most sponges associate with microbes such as fungi. To solve the problem of sponge availability, it is necessary to isolate compounds from marine-derived fungi due to their feasibility and advantages. This study, thus, highlights that the most prominent genera to produce metabolites active as antibacterials and antibiofilm were Aspergillus, Penicillium, Neosartorya, and Trichoderma. The summarized data of isolated compounds related to antibacterial and antibiofilm activities until 2022 included anthraquinones, sterigmatocystin analogs, hydroxy pyrrolidine alkaloids, helvolic acid derivatives, lactones, prenylated phenylbutyrolactones, citrinin and derivatives, bisthiodiketopiperazine, cyclotetrapeptides, dihydrochromone dimers, amino lipopeptides, furan derivatives, aspiron-derivatives, halogenated metabolites, and alkaloids. Since the biofilm mechanism is very complex, some antibacterial compounds do not necessarily work as antibiofilms. Nevertheless, it can be concluded that compounds produced from sponge-associated fungi have the potential to be developed as new antibacterial and antibiofilm agents although still require further investigation related to the mechanism of actions of the compounds. © 2024 Dyan Wigati et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
| Item Type: | Article |
|---|---|
| Additional Information: | Cited by: 4; All Open Access, Gold Open Access |
| Uncontrolled Keywords: | alkaloid; anthraquinone derivative; antiinfective agent; ceftazidime; cholinesterase; citrinin; colistin; extended spectrum beta lactamase; furan; furan derivative; indole alkaloid; lipopeptide; nitric oxide; oxacillin; piperazinedione; polyketide; sterigmatocystin; antibacterial activity; antifungal activity; antimicrobial activity; Article; Aspergillus oryzae; Bacillus subtilis; biofilm; Candida albicans; Candida glabrata; Cryptococcus neoformans; Curvularia lunata; cyanobacterium; cytotoxicity; Enterococcus faecalis; Escherichia coli; fungus; Fusarium graminearum; Klebsiella pneumoniae; LC50; LD50; marine environment; methicillin resistant Staphylococcus aureus; minimum inhibitory concentration; Mycobacterium smegmatis; Neosartorya; nonhuman; Penicillium; phytochemistry; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; zone of inhibition |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Faculty of Pharmacy |
| Depositing User: | Muh Aly Mubarok |
| Date Deposited: | 03 Jul 2025 08:29 |
| Last Modified: | 03 Jul 2025 08:29 |
| URI: | https://ir.lib.ugm.ac.id/id/eprint/19196 |
